Hennion & Walsh Asset Management Inc. lifted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 125.2 ...
The startup behind a Harvard geneticist's quest to revive the woolly mammoth just received a big boost. Colossal Biosciences, ...
Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with ...
Scientists are pioneering and refining three techniques in their attempts to revive lost and rare species: cloning, genetic ...